All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. [Effectiveness and cost-effectiveness of treatments for smoking cessation]

    KCE Reports 1 (2004) 22 juillet 2004 (1st print), août 2005 (2nd print)

    https://kce.fgov.be/en/effectiveness-and-cost-effectiveness-of-treatments-for-smoking-cessation

  2. [Leukoreduction. A possible measure in the context of a national blood safety policy]

    KCE Reports 4 (2004)

    https://kce.fgov.be/en/leukoreduction-a-possible-measure-in-the-context-of-a-national-blood-safety-policy

  3. [Endovascular Treatment of Carotid stenosis]

    KCE Reports 13 (2005)

    https://kce.fgov.be/en/endovascular-treatment-of-carotid-stenosis

  4. [Molecular Diagnostics in Belgium]

    KCE Reports 20 (2005)

    https://kce.fgov.be/en/molecular-diagnostics-in-belgium

  5. [HTA Positron Emission Tomography in Belgium]

    KCE Reports 22 (2005)

    https://kce.fgov.be/en/hta-positron-emission-tomography-in-belgium

  6. [Elective endovascular treatment of the abdominal aortic aneurysm (AAA)]

    KCE Reports 23 (2005)

    https://kce.fgov.be/en/elective-endovascular-treatment-of-the-abdominal-aortic-aneurysm-aaa

  7. [Natriuretic peptides in the diagnostic work-up of patients with suspected heart failure]

    KCE Reports 24 (2005)

    https://kce.fgov.be/en/natriuretic-peptides-in-the-diagnostic-work-up-of-patients-with-suspected-heart-failure

  8. [Preliminary recommandations for pharmacoeconomic evaluations in Belgium]

    KCE Reports 28 (2006)

    https://kce.fgov.be/en/preliminary-recommandations-for-pharmacoeconomic-evaluations-in-belgium

  9. Pharmacological and surgical treatment of obesity. Residential care for severely obese children in Belgium.

    KCE Reports 36 (2006) August 2006 (3rd edition ; 2nd edition : July 2006 ; 1st edition : June 2006)

    https://kce.fgov.be/en/pharmacological-and-surgical-treatment-of-obesity-residential-care-for-severely-obese-children-in

  10. HTA Magnetic Resonance Imaging

    KCE Reports 37 (2006)

    https://kce.fgov.be/en/hta-magnetic-resonance-imaging

  11. [An evaluation procedure for the emerging medical technologies]

    KCE Reports 44 (2006)

    https://kce.fgov.be/en/an-evaluation-procedure-for-the-emerging-medical-technologies

  12. [Screening for Colorectal Cancer : current evidence and budget impact for Belgium.]

    KCE Reports 45 (2006)

    https://kce.fgov.be/en/screening-for-colorectal-cancer-current-evidence-and-budget-impact-for-belgium

  13. [Organisation and financing of musculoskeletal and neurological rehabilitation in Belgium]

    KCE Reports 57 (2007)

    https://kce.fgov.be/en/organisation-and-financing-of-musculoskeletal-and-neurological-rehabilitation-in-belgium

  14. HPV Vaccination for the Prevention of Cervical Cancer in Belgium: Health Technology Assessment

    KCE Reports 64 (2007)

    https://kce.fgov.be/en/hpv-vaccination-for-the-prevention-of-cervical-cancer-in-belgium-health-technology-assessment

  15. Guidelines for Pharmacoeconomic Evaluations in Belgium

    KCE Reports 78 (2008)

    https://kce.fgov.be/en/guidelines-for-pharmacoeconomic-evaluations-in-belgium

  16. [Radioisotopes Reimbursement in Belgium]

    KCE Reports 79 (2008)

    https://kce.fgov.be/en/radioisotopes-reimbursement-in-belgium

  17. 64-Slice computed tomography imaging of coronary arteries in patients suspected for coronary artery disease

    KCE Reports 82 (2008)

    https://kce.fgov.be/en/64-slice-computed-tomography-imaging-of-coronary-arteries-in-patients-suspected-for-coronary-artery

  18. Threshold values for cost-effectiveness in health care

    KCE Reports 100 (2008)

    https://kce.fgov.be/en/threshold-values-for-cost-effectiveness-in-health-care

  19. [Magnetic Resonance Imaging: cost analysis]

    KCE Reports 106 (2009)

    https://kce.fgov.be/en/magnetic-resonance-imaging-cost-analysis

  20. Policies for Rare Diseases and Orphan Drugs

    KCE Reports 112 (2009)

    https://kce.fgov.be/en/policies-for-rare-diseases-and-orphan-drugs

Pages